SpectraBase Spectrum ID |
JGpFMm2qwVM |
Name |
Pyrovalerone |
CAS Registry Number |
3563-49-3 |
Classification |
Cathinone analog designer drug |
Comments |
Spectrum verified by crosschecking against external libraries (one reference spectrum with similarity >= 99% found) |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.15 (d) (1) |
DEA Controlled Substance Name |
Pyrovalerone |
DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
DEA Controlled Substances Code Number |
1485 |
DEA Schedule |
Schedule V |
DEA Section |
Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers |
Exact Mass |
245.177964364 u |
Formula |
C16H23NO |
InChI |
InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3 |
InChIKey |
SWUVZKWCOBGPTH-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
245.366 g/mol |
Nominal Mass |
245 u |
Quality |
999 |
Retention Index |
1876 |
SMILES |
C(C(C=1C=CC(=CC1)C)=O)(N1CCCC1)CCC |
SPLASH |
splash10-004i-4900000000-37f25161d332703e9b45 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one |
Technique |
GC/MS |
Wiley ID |
DD2024_015466 |